| ACNPs | Antibody-conjugated nanoparticles |
| AP-NLC | ARV-825-loaded PEGylated NLCs |
| API | Active pharmaceutical ingredient |
| AR | Androgen receptor |
| ARV-SNEP | ARV-825-loaded self-nanoemulsifying preconcentrate |
| ASDs | Amorphous solid dispersion |
| BBB | Blood–brain barrier |
| CME | Camel milk-derived exosome |
| CRBN | Cereblon |
| DS-PLGA | Disulfide-linked poly (lactic-co-glycolic acid) |
| EPR | Enhanced permeability and retention |
| ER | Estrogen receptor |
| GALARV | Galactose-decorated nanoliposomal formulation |
| GSH | Glutathione |
| HCC | Hepatocellular carcinoma |
| LLCM | Lung cancer cell membrane |
| LNP | Lipid nanoparticles |
| MPRO | Folate-PEG-PROTAC micelles |
| MSPM | Mixed-shell polymeric micelle |
| MZ1-NPs | MZ1-loaded polymeric nanoparticles |
| nChap | Nanochaperone-based |
| NLC | Nanostructured lipid carrier |
| NSCLC | Non-small cell lung cancer |
| PCL | Polycaprolactone |
| PDSA | Poly(disulfide amide) |
| PEG | Polyethylene glycol |
| PEI | Polyethyleneimine |
| PEO-PPO-PEO | Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) |
| PGDAT | Self-assembling PROTAC nanoparticle |
| PLA | Polylactide |
| PLGA | Poly(lactic-co-glycolic acid) |
| POI | Protein of interest |
| PROTAC | Proteolysis targeting chimeras |
| PVA | Polyvinyl alcohol |
| PVP | Polyvinylpyrrolidone |
| RCNprotac | X-ray radiation responsive PROTAC nanomicelle |
| ROS | Reactive oxygen species |
| SNEDDS | Self-nanoemulsifying drug delivery system |
| SP | Substance P |
| TAMs | Tumor-associated macrophages |
| TNBC | Triple-negative breast cancer |
| UPS | Ubiquitin–proteosome system |
| VHL | Von Hippel–Lindau |